Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its shares ...

The majority of other information websites display prices from a single source, most of the time from one retail broker-dealer. At FXStreet, traders get interbank rates coming from a systematic ...